Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Akoustis Technologies Inc buy Wedbush

Akoustis Technologies Inc
Start price
€0.001
19.08.26 / 50%
Target price
€30.24
19.08.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 19.08.27. The prediction end date can be changed by Wedbush at any time.
Performance without dividends (%)
Name 1w
Akoustis Technologies Inc -
iShares Core DAX® -1.059%
iShares Nasdaq 100 -2.387%
iShares Nikkei 225® -4.361%
iShares S&P 500 -1.778%

Comments by Wedbush for this prediction

In the thread Akoustis Technologies Inc diskutieren
Prediction Buy
Perf. (%) -
Target price 30.237
Change
Ends at 19.08.27

Aktis Oncology (AKTS) is now covered by Wedbush. They set an "outperform" rating and a $35.00 price target on the stock.
Ratings data for AKTS provided by MarketBeat

Wedbush 
0
Report Share
19.08.26